First Microdacyn (SOS) to the Pacific Islands
September sees the first Microdacyn Super-Oxidised Solution (SOS) being supplied to the Pacific Islands.
The Cook Islands, like New Zealand experience a high rate of skin sores and skin infections. The infections predominantly occur in children and are caused by the bacteria Staphylococcus aureus and Streptococcus pyogenes.
Microdacyn is a significant advance in the treatment of acute and chronic wounds, working to reduce the time taken wound healing:
Microdacyn is used to irrigate and debride the wond area creating an optimal moist healing environment
Physical kill of microbes including bacteria, drug resistant bacteria, fungi, viruses and spores.
The therapeutic benefits of Microdacyn use include reduction of inflammation and improved wound healing.
Microdacyn is non-antibiotic and non-cytotoxic to be well tolerated and minimises the risk of developing drug resistance.
For further information please see our Medicines page.
Microdacyn is a Medsafe WAND listed Medical Device. No prescription is required. Full information is available on product page.